FN

Evolutionary Genomics IncOOTC FNAM Stock Report

Last reporting period 31 Dec, 2022

Updated 19 Sep, 2024

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

FNAM Stock Analysis

FN

Uncovered

Evolutionary Genomics Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0

Dividend yield

Shares outstanding

6.655 B

Evolutionary Genomics, Inc. is a genomics research and development company, which engages in the identification and validation of genes. The company is headquartered in Castle Rock, Colorado and currently employs 2 full-time employees. The company went IPO on 2011-03-03. The firm is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. The company performs research on crops, including rice, corn, soybeans, wheat, cotton, cowpeas, beans, tomatoes, and cassava. The firm offers its technology through Adapted Traits Platform (ATP), which is used to perform molecular evolution analysis to identify positively selected genes that have an impact on traits of interest. The firm has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.

View Section: Eyestock Rating